Мultimodal program «Fast trасk surgery» in the treatment of mammary gland cancer
Objective. Improvement of immediate and late results of treatment of mammary gland cancer (MGC), using elaboration and introduction of multimodal program «Fast track surgery» (FTS) in aspect of performance of a one-staged oncoplastic and reconstructive-restoration operations.
Маterials and methods. The treatment results were investigated in 749 patients, suffering MGC Stages T1-4 N0-3 M0 from Dec. 2010 tо Dec. 2014 yr. The patients have aged from 18 tо 70 yrs old. The main group (treatment in accordance to the FTS program) consisted of 253 patients, and a control one – of 496 patients, who were treated in accordance to conventional standards.
Results. The main group patients have been on stationary treatment (14.27 ± 7.00) days at average, and the control one – (20.11 ± 7.70) days of stationary stay at average (p < 0.001). The main group patients, who have had more severe stages of the disease, stayed in stationary by 8 days lesser, comparing with patients of a control group. Average term of the patients’ stationary stay, in whom adjuvant chemotherapy (АCHTH) was performed, have constituted 16.4 days, while in those, in whom АCHTH was conducted, - 20.1 days (р < 0.001). Difference between term of the patients’ stationary stay in the main group, to whom ACHTH was conducted and to whom it was not, was in 2.7 times lesser, comparing with this index in a control group.
Conclusion. The investigation data gives background to recommend a FTS program for wide introduction into medical practice, because its efficacy in the MGC surgery was confirmed, including the one-staged oncoplastic and reconstructive-restoration operations. Gradual shortening of the stationary treatment duration gave possibility from 2008 tо 2018 years to enhance the operated patients quantity by 75%.
2. Shchepotin IB, Smolanka II, Skliar SIu, Sydorchuk OI, Motuziuk IM, Ivankova OM, Kostryba OI. Rak hrudnoi zalozy. Suchasni aspekty khirurhichnoho likuvannia (za danymy Natsionalnoho instytutu raku). Klinichna onkolohiia. 2013;(1):38-43. [In Ukrainian].
3. Sydorchuk OI, Motuziuk IM, Zaichuk VV, Lobanova OIe, Liashenko AO, Molid SO, et al. Metod drenuvannia ran pislia radykalnykh modeliuiuchykh operatsii u khvorykh na rak hrudnoi zalozy. Onkolohiia. 2016;18 (1):55-8. [In Ukrainian].
4. Shchepotin IB, Motuziuk IM, Sydorchuk OI, Pap LS, Yehorov IV, Sydorenko KD vynakhidnyky; Bogomolets National Medical University, National Cancer Institite patentovlasnyki. Sposib vedennia khvorykh na rak molochnoi zalozy na etapi khirurhichnoho likuvannia. Patent Ukrainy No 54579. 2010 lyst 10. [In Ukrainian].
5. Motuzyuk I, Sydorchuk O, Kovtun N, Kostiuchenko Y. Synchronous and metachronous breast cancer in Ukraine. Breast Dis. 2017; 37(2):83-93. https://doi.org/10.3233/BD-170285.
6. Motuzyuk I, Sydorchuk O, Kovtun N, Palian Z, Kostiuchenko Y. Analysis of Trends and Factors in Breast Multiple Primary Malignant Neoplasms. Breast Cancer: Basic and Clinical Research. 2018 January 29; 12:1-9. https://doi.org/10.1177/1178223418759959.
7. Hainsworth AJ, Lobo CR, Williams P, Case C, Surridge F, Sharma AK, Banerjee D. '23 h Model' for breast surgery: an early experience. Breast. 2013 Oct;22(5):898-901. https://doi.org/10.1016/j.breast.2013.04.007.
8. Mertz BG, Kroman N, Williams H, Kehlet H. Fast-track surgery for breast cancer is possible. Dan Med J. 2013 May;60(5):A4615.
9. Dumestre DO, Redwood J, Webb CE, Temple-Oberle C. Enhanced Recovery After Surgery (ERAS) Protocol Enables Safe Same-Day Discharge After Alloplastic Breast Reconstruction. Plast Surg (Oakv). 2017 Nov;25(4):249-254. https://doi.org/10.1177/2292550317728036.
10. Bonde C, Khorasani H, Eriksen K, Wolthers M, Kehlet H, Elberg J. Introducing the fast track surgery principles can reduce length of stay after autologous breast reconstruction using free flaps: A case control study. J Plast Surg Hand Surg. 2015;49(6):367-71. https://doi.org/10.3109/2000656X.2015.1062387.
11. Bonde CT, Khorasani H, Elberg J, Kehlet H. Perioperative Optimization of Autologous Breast Reconstruction. Plast Reconstr Surg. 2016 Feb;137(2):411-414. https://doi.org/10.1097/01.prs.0000475749.40838.85.
12. Offodile AC 2nd, Gu C, Boukovalas S, Coroneos CJ, Chatterjee A, Largo RD, Butler C. Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2018 Oct 10. https://doi.org/10.1007/s10549-018-4991-8.
13. Ng YY, Chan PM, Chen JJ, Seah MD, Teo C, Tan EY. Adopting ambulatory breast cancer surgery as the standard of care in an asian population. Int J Breast Cancer. 2014;2014:672743. https://doi.org/10.1155/2014/672743.
14. Oh C, Moriarty J, Borah BJ, Mara KC, Harmsen WS, Saint-Cyr M, Lemaine V. Cost analysis of enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg. 2018 Jun;71(6):819-826. https://doi.org/10.1016/j.bjps.2018.02.018.
This work is licensed under a Creative Commons Attribution 4.0 International License.